Moelis & Company (NYSE:MC) Stock Rating Upgraded by BMO Capital Markets

Moelis & Company (NYSE:MCGet Free Report) was upgraded by analysts at BMO Capital Markets to a “hold” rating in a research report issued on Thursday,Zacks.com reports.

A number of other analysts have also recently issued reports on the company. Keefe, Bruyette & Woods upped their target price on Moelis & Company from $69.00 to $89.00 and gave the company an “outperform” rating in a research report on Monday, July 14th. Morgan Stanley increased their price objective on Moelis & Company from $74.00 to $90.00 and gave the stock an “overweight” rating in a research report on Monday, September 8th. Wells Fargo & Company increased their price objective on Moelis & Company from $50.00 to $64.00 and gave the stock an “equal weight” rating in a research report on Friday, July 11th. Zacks Research raised Moelis & Company from a “hold” rating to a “strong-buy” rating in a research report on Monday, August 18th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Moelis & Company in a research report on Saturday, September 27th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $70.29.

Read Our Latest Stock Analysis on MC

Moelis & Company Stock Down 0.7%

Shares of NYSE MC opened at $68.34 on Thursday. The stock has a market cap of $5.36 billion, a PE ratio of 26.91 and a beta of 1.77. Moelis & Company has a 52-week low of $47.00 and a 52-week high of $82.89. The business has a 50-day moving average price of $72.11 and a 200 day moving average price of $63.48.

Moelis & Company (NYSE:MCGet Free Report) last announced its earnings results on Thursday, July 24th. The asset manager reported $0.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.32 by $0.21. The firm had revenue of $365.38 million during the quarter, compared to analysts’ expectations of $269.57 million. Moelis & Company had a return on equity of 42.72% and a net margin of 14.31%.The business’s revenue was up 38.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.18 EPS. Sell-side analysts anticipate that Moelis & Company will post 2.97 earnings per share for the current year.

Insider Activity at Moelis & Company

In related news, Director Kenneth Shropshire sold 2,615 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $72.52, for a total value of $189,639.80. Following the completion of the transaction, the director directly owned 7,109 shares of the company’s stock, valued at $515,544.68. This trade represents a 26.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, General Counsel Osamu R. Watanabe sold 6,340 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $72.64, for a total value of $460,537.60. Following the completion of the transaction, the general counsel directly owned 131 shares of the company’s stock, valued at $9,515.84. The trade was a 97.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. 6.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Moelis & Company

Several hedge funds have recently bought and sold shares of MC. Charles Schwab Investment Management Inc. increased its stake in Moelis & Company by 214.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,942,299 shares of the asset manager’s stock valued at $171,713,000 after purchasing an additional 2,006,747 shares in the last quarter. Azora Capital LP purchased a new position in Moelis & Company during the second quarter worth $46,762,000. The Manufacturers Life Insurance Company increased its position in Moelis & Company by 1,161.8% during the second quarter. The Manufacturers Life Insurance Company now owns 661,594 shares of the asset manager’s stock worth $41,231,000 after buying an additional 609,162 shares in the last quarter. Goldman Sachs Group Inc. increased its position in Moelis & Company by 32.6% during the first quarter. Goldman Sachs Group Inc. now owns 2,356,893 shares of the asset manager’s stock worth $137,548,000 after buying an additional 579,529 shares in the last quarter. Finally, Norges Bank purchased a new position in Moelis & Company during the second quarter worth $31,248,000. 91.53% of the stock is owned by hedge funds and other institutional investors.

About Moelis & Company

(Get Free Report)

Moelis & Co operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments.

Featured Articles

Analyst Recommendations for Moelis & Company (NYSE:MC)

Receive News & Ratings for Moelis & Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Moelis & Company and related companies with MarketBeat.com's FREE daily email newsletter.